Third Quarter 3

Third Quarter

3 Interim Consolidated Financial Statements (unaudited)

For the quarter ended September 30, 2021

Intact Financial Corporation

INTACT FINANCIAL CORPORATION

INTACT FINANCIAL CORPORATION 1

Interim Consolidated financial statements (unaudited)

Table of contents

Interim Consolidated financial statements Interim Consolidated balance sheets (unaudited) ................................................................................................ 2

Interim Consolidated statements of income (unaudited) ...................................................................................... 3 Interim Consolidated statements of comprehensive income (unaudited) ............................................................ 4 Interim Consolidated statements of changes in equity (unaudited) ..................................................................... 5 Interim Consolidated statements of cash flows (unaudited) ................................................................................ 6

Notes to the interim Consolidated financial statements (unaudited) Note 1 – Status of the Company .......................................................................................................................... 7 Note 2 – Basis of presentation............................................................................................................................. 7 Note 3 – Summary of significant accounting policies ........................................................................................... 9 Note 4 – Business combination ......................................................................................................................... 11 Note 5 – Investments ......................................................................................................................................... 13 Note 6 – Financial liabilities related to investments ........................................................................................... 15 Note 7 – Derivative financial instruments .......................................................................................................... 16 Note 8 – Fair value measurement ..................................................................................................................... 18 Note 9 – Financial risk ....................................................................................................................................... 19 Note 10 – Claims liabilities and reinsurance ...................................................................................................... 21 Note 11 – Other assets and other liabilities ....................................................................................................... 23 Note 12 – Asset held for sale............................................................................................................................. 24 Note 13 – Debt outstanding ............................................................................................................................... 25 Note 14 – Common shares and preferred shares.............................................................................................. 28 Note 15 – Non-controlling interests ................................................................................................................... 29 Note 16 – Capital management ......................................................................................................................... 30 Note 17 – Net investment income ...................................................................................................................... 31 Note 18 – Net gains (losses) ............................................................................................................................. 32 Note 19 – Income taxes ..................................................................................................................................... 34 Note 20 – Earnings per share ............................................................................................................................ 35 Note 21 – Share-based payments ..................................................................................................................... 36 Note 22 – Employee future benefits .................................................................................................................. 37 Note 23 – Segment information ......................................................................................................................... 40 Note 24 – Additional information on the interim Consolidated statements of cash flows ................................... 43 Note 25 – Standards issued but not yet effective .............................................................................................. 43


2 INTACT FINANCIAL CORPORATION

Interim Consolidated balance sheets (unaudited) (In millions of Canadian dollars, except as otherwise noted)

As at Note September 30,

2021 December 31,

2020

Assets Investments 5

Cash and cash equivalents $ 3,014 $ 917

Debt securities 24,956 14,098

Preferred shares 1,923 1,552

Common shares 5,194 3,779

Investment property 552 -

Loans 986 284

Total investments 36,625 20,630

Premiums receivable 7,916 3,822

Reinsurance assets 10 5,736 1,533

Income taxes receivable 111 7

Deferred tax assets 617 179

Deferred acquisition costs 2,060 1,089

Other assets 11 3,050 1,201

Investments in associates and joint ventures 751 811

Property and equipment 803 520

Intangible assets 4,632 2,514

Goodwill 3,013 2,813

Asset held for sale 12 859 -

Total assets $ 66,173 $ 35,119

Liabilities

Claims liabilities 10 $ 25,006 $ 12,780

Unearned premiums 12,006 6,256

Financial liabilities related to investments 6 531 89

Income taxes payable 101 149

Deferred tax liabilities 730 279

Other liabilities 11 6,230 2,942

Debt outstanding 13 5,324 3,041

Total liabilities 49,928 25,536

Equity Common shares 14 7,576 3,265 Preferred shares 14 1,175 1,175 Contributed surplus 197 187 Retained earnings 5,600 4,547 Accumulated other comprehensive income (loss)

Available-for-sale securities 574 412 Translation of foreign operations, net of hedges 1 (2) Other - (1)

Equity attributable to shareholders 15,123 9,583

Equity attributable to non-controlling interests 15 1,122 -

Total equity 16,245 9,583

Total liabilities and equity $ 66,173 $ 35,119

See accompanying notes to the interim Consolidated financial statements.



Interim Consolidated statements of income (unaudited) (In millions of Canadian dollars, except as otherwise noted)

For the periods ended September 30, Three months Nine months

Note 2021 2020 2021 2020

Direct premiums written $ 5,719 $ 3,269 $ 12,676 $ 9,215 Premiums ceded (440) (125) (832) (402)

Net premiums written 5,279 3,144 11,844 8,813 Change in unearned premiums (329) (280) (609) (471)

Net earned premiums 4,950 2,864 11,235 8,342 Other underwriting revenues 77 34 157 99 Investment income 17 202 148 509 450 Other revenues 116 81 313 236

Total revenues 5,345 3,127 12,214 9,127

Net claims incurred 10 (2,883) (1,658) (6,171) (5,220) Underwriting expenses (1,718) (933) (3,946) (2,764) Investment expenses 17 (11) (5) (23) (16) Net gains (losses) 18 (88) 13 55 136 Gain on bargain purchase 4 4 - 204 - Share of profit from investments in associates and joint ventures 22 16 71 35 Finance costs (45) (29) (111) (86) Acquisition, integration and restructuring costs (115) (25) (296) (62) Other expenses (120) (80) (300) (261)

Income before income taxes 391 426 1,697 889 Income tax benefit (expense) 19 (91) (92) (310) (185)

Net income $ 300 $ 334 $ 1,387 $ 704

Net income attributable to: Shareholders

295 334

1,375 704

Non-controlling interests 5 - 12 -

$ 300 $ 334 $ 1,387 $ 704

Weighted-average number of common shares outstanding

(in millions) 20

176.1

143.0

157.8

143.0 Earnings per common share, basic and diluted (in dollars) 20 $ 1.60 $ 2.25 $ 8.46 $ 4.65

Dividends paid per common share (in dollars) $ 0.83 $ 0.83 $ 2.49 $ 2.49




Interim Consolidated statements of comprehensive income (unaudited) (In millions of Canadian dollars, except as otherwise noted)

For the periods ended September 30, Three months Nine months Note 2021 2020 2021 2020

Net income $ 300 $ 334 $ 1,387 $ 704

Other comprehensive income (loss)

Available-for-sale securities: net changes in unrealized gains (losses) (46) 262 350 (156) income tax benefit (expense) 4 (68) (136) 50 reclassification of net losses (gains) 74 (29) (118) 53 income tax (benefit) expense 14 7 66 (16)

46 172 162 (69)

Cash flow hedges: 7 net changes in unrealized gains (losses) - - (32) - reclassification of net losses (gains) - - 32 -

- - - -

Foreign exchange gains (losses) on: translation of foreign operations 94 (90) 4 103 net investment hedges (41) 52 16 (54) income tax benefit (expense) - (1) (1) 4

53 (39) 19 53

Other, net of tax - (1) 1 (5)

Items that may be reclassified subsequently to net income 99 132 182 (21)

Net actuarial gains (losses) on employee future benefits 22 25 (32) 337 47 income tax benefit (expense) (3) 9 (130) (12)

Items that will not be reclassified subsequently to net income 22 (23) 207 35

Other comprehensive income (loss) 121 109 389 14

Total comprehensive income $ 421 $ 443 $ 1,776 $ 718

Total comprehensive income attributable to: Shareholders 409 443 1,748 718 Non-controlling interests 12 - 28 -

$ 421 $ 443 $ 1,776 $ 718




Interim Consolidated statements of changes in equity (unaudited) (In millions of Canadian dollars, except as otherwise noted)

Equity attributable to shareholders

Note Common

shares Preferred

shares Contributed

surplus Retained earnings

Accumulated other compre-

hensive income (loss)

Equity attributable

to non-controlling

interests Total

Equity

Balance as at January 1, 2021 $ 3,265 $ 1,175 $ 187 $ 4,547 $ 409 $ - $ 9,583

Net income - - - 1,375 - 12 1,387 Other comprehensive income (loss) - - - 207 166 16 389

Total comprehensive income (loss) - - - 1,582 166 28 1,776

Common shares issued 14 4,311 - - - - - 4,311 Dividends declared on: common shares

-

-

-

(466) - -

(466)

preferred shares - - - (40) - - (40) Share-based payments - - 10 (21) - - (11) Non-controlling interests:

dividends 15 - - - - - (14) (14) business combination 4 - - - - - 1,108 1,108

Other - - - (2) - - (2)

Balance as at September 30, 2021 $ 7,576 $ 1,175 $ 197 $ 5,600 $ 575 $ 1,122 $ 16,245

Balance as at January 1, 2020 $ 3,265 $ 1,028 $ 170 $ 3,959 $ 325 $ - $ 8,747 Net income - - - 704 - - 704 Other comprehensive income (loss) - - - 35 (21) - 14

Total comprehensive income (loss) - - - 739 (21) - 718

Preferred shares issued - 147 - - - - 147 Dividends declared on: common shares

- - - (356) - - (356)

preferred shares - - - (39) - - (39) Share-based payments - - 7 (9) - - (2)

Balance as at September 30, 2020 $ 3,265 $ 1,175 $ 177 $ 4,294 $ 304 $ - $ 9,215




Interim Consolidated statements of cash flows (unaudited) (In millions of Canadian dollars, except as otherwise noted)

Three months Nine months For the periods ended September 30, Note 2021 2020 2021 2020

Operating activities Income before income taxes $ 391 $ 426 $ 1,697 $ 889 Income tax received (paid), net (190) (141) (573) (295) Contributions to the defined benefit pension plans (18) (13) (179) (38) Share-based payments - - (34) (7) Net losses (gains) 18 88 (13) (55) (136) Gain on bargain purchase 4 (4) - (204) - Adjustments for non-cash items 24 225 121 458 330 Changes in other operating assets and liabilities 24 293 145 479 122 Changes in net claims liabilities 10 485 254 646 807

Net cash flows provided by (used in) operating activities 1,270 779 2,235 1,672

Investing activities Business combination, net of cash acquired 4 - - (11,076) - Proceeds from the disposal of certain RSA assets 4 - - 7,209 - Proceeds from sale of investments 4,020 1,777 12,044 9,162 Purchases of investments (5,152) (2,274) (12,552) (10,436) Purchases of brokerages and other equity investments, net (23) (71) (79) (128) Purchases of intangibles and property and equipment, net (106) (42) (221) (108)

Net cash flows provided by (used in) investing activities (1,261) (610) (4,675) (1,510)

Financing activities Payment of lease liabilities (35) (15) (70) (44) Proceeds from (repurchase of) securities sold under repurchase agreements

6

(252) - - (20) Payment of contingent consideration related to business combinations

-

-

(15)

-

Proceeds from issuance of debt, net of issuance costs 13 - - 1,814 298 Repayment of debt 13 (410) (47) (1,356) (47) Borrowing (repayment) on the credit facility, net 472 - 472 (163) Proceeds from issuance of common shares, net of issuance costs

14

- - 4,263 - Proceeds from issuance of preferred shares, net of issuance costs

-

-

-

146

Repurchase of common shares for share-based payments (6) (4) (59) (45) Payment of dividends on common shares (146) (119) (466) (356) Payment of dividends on preferred shares (14) (13) (40) (39) Payment of dividends to non-controlling interests 15 (7) - (14) -

Net cash flows provided by (used in) financing activities (398) (198) 4,529 (270)

Net increase (decrease) in cash and cash equivalents (389) (29) 2,089 (108)

Cash and cash equivalents, beginning of period 3,382 875 917 936 Exchange rate differences on cash and cash equivalents 21 (9) 8 9

Cash and cash equivalents, end of period $ 3,014 $ 837 $ 3,014 $ 837

Composition of cash and cash equivalents Cash 1,868 725 1,868 725 Cash equivalents 1,146 112 1,146 112

Cash and cash equivalents, end of period $ 3,014 $ 837 $ 3,014 $ 837

Other relevant cash flow disclosures – operating activities Interest paid 40 25 122 82 Interest received 106 73 299 250 Dividends received 77 67 220 197



Notes to the interim Consolidated financial statements (unaudited) (In millions of Canadian dollars, except as otherwise noted)


Glossary of abbreviations

ABS Asset-backed securities IBOR Interbank offered rate

AFS Available-for-sale IFRS International Financial Reporting Standards

AOCI Accumulated other comprehensive income JV Joint ventures

ARR Alternative reference rate LTIP Long-term incentive plan

ATRA Alberta Tax and Revenue Administration MBS Mortgage-backed securities

CAD Canadian Dollar MCT Minimum capital test (Canada)

CALs Company action levels MD&A Management’s Discussion and Analysis

CRA Canada Revenue Agency MYA Market yield adjustment

DB Defined benefits NCI Non-controlling interests

DKK (kr.) Danish krone, Denmark’s official currency NEP Net earned premiums

DPW Direct premiums written NOI Net operating income

DSU Deferred share unit OCI Other comprehensive income

EBITA Earnings before interest, taxes, and amortization P&C Property and casualty

EPS Earnings per share to common shareholders PTOI Pre-tax operating income

ESPP Employee share purchase plan RBC Risk-based capital (US)

EUR (€) Currency of the European Union RQ Revenu Quebec

FVTPL Fair value through profit and loss SCR Solvency Capital Requirement (Europe)

GBP (£) British pound sterling, UK’s official currency UK United Kingdom

IAS International Accounting Standard UK&I United Kingdom and International

IASB International Accounting Standards Board US United States

IBNR Insurance claims incurred but not reported by policyholders USD US Dollar

Note 1 – Status of the Company

Intact Financial Corporation (the “Company”), incorporated under the Canada Business Corporations Act, is domiciled in Canada and its shares are publicly traded on the Toronto Stock Exchange (TSX: IFC). The Company has investments in wholly owned subsidiaries which operate principally in the Canadian, UK and US P&C insurance market. The Company, through its operating subsidiaries, principally underwrites automobile, home, as well as commercial P&C contracts to individuals and businesses. Effective February 18, 2020, OneBeacon Insurance Group Holdings, Ltd. was renamed Intact Insurance Group USA Holdings Inc. (referred to as “Intact U.S. (OneBeacon)”). On June 1, 2021, the Company completed the acquisition of RSA Insurance Group plc (“RSA”), referred to as the "RSA acquisition". Refer to Note 4.1 – Business combination for more details.

These interim Consolidated financial statements include the accounts of the Company and its subsidiaries.

The registered office of the Company is 700 University Avenue, Toronto, Canada.

Note 2 – Basis of presentation

2.1 Statement of compliance

These interim Consolidated financial statements are prepared in accordance with IAS 34 – Interim Financial Reporting. These interim

Consolidated financial statements and the accompanying notes were authorized for issue in accordance with a resolution of the Board

of Directors on November 9, 2021.

2.2 Preparation and presentation of financial statements

These interim Consolidated financial statements are condensed financial statements and should be read in conjunction with the

Company’s annual Consolidated financial statements for the year ended December 31, 2020.

The Company presents its interim Consolidated balance sheets broadly in order of liquidity.




2.3 Seasonality

The P&C insurance business is seasonal in nature. While net premiums earned are generally stable from quarter to quarter,

underwriting results are driven mainly by weather conditions which may vary significantly between quarters.

2.4 Foreign currency translation

Table 2.1 – Exchange rates used

As at Average rate for the

three-month periods ended Average rate for the

nine-month periods ended

September 30,

2021 December 31,

2020 September 30,

2021 September 30,

2020 September 30,

2021 September 30,

2020

USD vs CAD 1.26685 1.27210 1.25953 1.33228 1.25123 1.35371 GBP vs CAD 1.70676 1.73972 1.73542 n/a 1.73284 n/a EUR vs CAD 1.46739 1.55412 1.48454 n/a 1.49661 n/a DKK vs CAD1 0.19732 n/a 0.19962 n/a 0.20124 n/a

1 Average rate for the nine-month period ended reflects the period from June 1 to September 30, 2021, in relation to the RSA acquisition.

2.5 COVID-19 pandemic

On March 11, 2020, COVID-19 was declared a pandemic by the World Health Organization. The magnitude of the impact of the COVID-19 crisis on the economy and financial markets continues to evolve while also contributing to increased market volatility and changes to the macroeconomic environment. The broadening economic restart, driven by support from governments and decent COVID-19 vaccination levels, supported continued positive momentum in equity markets in Q3-2021. Nevertheless, capital markets are expected to remain volatile until the COVID-19 crisis has passed and economies fully reopen.

The Company continues to manage the impact on its business and believes that its operations and financial position remain strong

and that it is well positioned to deal with this crisis. In addition, the effects of the COVID-19 crisis related to emerging coverage issues

and claims, including certain class actions relating to business interruption coverage and related defence costs, as well as other

indirect claims could negatively impact the Company’s claims reserves.

In Canada, most commercial policies, except in very limited instances, do not provide for business interruption coverage in the context

of a closure due to COVID-19 since direct physical loss or damage is required to trigger this coverage. The Company plans to contest

these class actions vigorously. In the event that these cases result in a significant judgment against the Company, the resulting liability

could be material. In the UK&I, the current assessment of Claims liabilities reflects recent court judgments in the UK and Ireland.

However, the resulting liability could be materially different from the current estimate as legal interpretations and regulatory

expectations develop and clarify the criteria for eligible claims and the extent to which losses recoverable under reinsurance

agreements responds in the manner the Company expects.

Based on information currently known, the Company does not believe that the outcome of these cases will have a material impact on its consolidated financial condition, cash flows, or results of operations. As the COVID-19 crisis continues to evolve, the extent to which it may impact the Company’s operations will depend on future developments including the effectiveness of measures to contain the spread of the virus, such as the retightening of lockdown measures, the effective roll out of vaccinations and actions that will be taken by governments and central banks to stabilize economic conditions. Consequently, the Company’s financial results will be subject to volatility. The increased uncertainty required management to use judgements, estimates and assumptions related to the COVID-19 crisis. Refer to Note 3.2 – COVID-19 pandemic of the Company’s annual Consolidated financial statements for the year ended December 31, 2020 for more details. The Company has also provided additional disclosures on the following areas impacted by COVID-19:

• The sensitivity analysis to market risk (refer to Note 9.1 – Sensitivity analysis to market risk);

• The customer relief measures announced (see below).




Customer relief measures

In 2020, the Company provided customer relief measures including premium reductions to reflect changes in driving habits and lower business activity resulting from COVID-19 as well as a cap and reduction in rates on renewal and new business. The Company also provided flexible payment options and immediate relief measures for small business customers. In March 2021, the Company announced new and additional support, equivalent to one month of premiums, for eligible personal auto customers in Canada to reflect changes in driving habits during the second wave of COVID-19 pandemic. The program closed during the second quarter of 2021. For the three and nine-month period ended September 30, 2021, these additional measures in 2021 negatively impacted both the DPW and NEP equally by nil and $105 million respectively.

Note 3 – Summary of significant accounting policies

The accounting policies applied during the nine-month period ended September 30, 2021, are the same as those described and

disclosed in Note 2 – Summary of significant accounting policies of the Company’s annual Consolidated financial statements for

the year ended December 31, 2020, except for the amendments to existing standards described below which were adopted on

January 1, 2021 and accounting policies newly applied in relation to the RSA acquisition.

3.1 Accounting policies adopted on January 1, 2021

Interest rate benchmark reform ‒ Phase 2

In August 2020, the IASB issued amendments to IFRS 9 – Financial instruments, IAS 39 – Financial instruments: recognition and measurement, IFRS 7 – Financial instruments: disclosures, IFRS 4 – Insurance contracts and IFRS 16 – Leases. The amendments complement those issued in 2019 and focus on the effects on financial statements when an entity replaces an old interest rate benchmark with an ARR as part of the IBOR reform. The amendments clarify that, if the contractual cash flows of a financial instrument are modified as a result of the reform, an entity updates the effective interest rate to reflect the change instead of derecognizing it or adjusting its carrying amount. In addition, hedge accounting relationships shall not be discontinued if changes are required by the reform, as long as the hedge meets other hedge accounting criteria.

As a result of the transition to ARRs, certain benchmark rates may be subject to discontinuance, changes in methodology, increased

volatility or decreased liquidity. The Company, as a holder of certain IBOR-based instruments, is exposed to increased financial,

operational, legal and regulatory risks as the rates transition. In order to manage those risks, the Company has established an

enterprise-wide IBOR Transition Working Group, supported by senior management, to coordinate the transition from IBORs to ARRs,

and to monitor the development and adoption of ARRs across the industry. The Company is progressing on its transition plan and

incorporating market developments as they arise.

The Company’s exposure to IBORs that have yet to transition to ARRs as at September 30, 2021 consists of financial assets of

approximately $210 million related to the USD LIBOR and $179 million related to GBP LIBOR. The Company holds other financial

instruments indexed to US LIBOR tenors which will mature before their related transition dates; therefore, no additional disclosure

was provided. The Company’s financial instruments exposed to the CDOR are indexed to tenors that will continue as benchmark

rates.

The amendments were adopted retrospectively with no impact on the interim Consolidated financial statements.




3.2 Accounting policies newly applied in relation to the RSA acquisition

a) Insurance contracts

Accounting policy and presentation were aligned on acquisition for all jurisdictions where the Company had previously adopted accounting policies. For new jurisdictions, certain local accounting practices were maintained as permitted by IFRS 4 - Insurance contracts.

b) Investment property and rental income

Investment property includes land and buildings mainly located in the UK which are held to earn rental income and are externally managed and not owner-occupied.

Investment property is initially measured at cost, including transaction costs, and is subsequently measured at fair value based on

revised estimates, with changes in fair value reported in Net gains (losses) in Net income. Rental income from the related operating

leases is recognized as Investment income in Net income on a straight-line basis over the length of the lease. It is classified as Level 3 in the fair value hierarchy and valued, at least annually at their highest and best use by external, independent valuers. The valuation techniques include the comparative method with reference to sales of other comparable buildings as well as discounted cash flow models which consider the net present value of cash flows to be generated from the properties. The cash flow streams reflect the current rent payable to lease expiry, at which point each unit is assumed to be re-let at its estimated rental value. The discount rate considers many factors such as recent transactions on similar properties, building location and quality, tenant credit quality and lease terms.

c) Derivative financial instruments and hedging

Fair value hedges – The Company uses “fixed to floating” interest rate swaps to hedge changes in the fair value of fixed income securities. The gains and losses on hedging instruments are recorded in Net gains (losses) in Net income. The change in fair value of the hedged item that is attributable to the hedged risk is transferred from AOCI to Net income. The Company uses foreign currency denominated debt, cross-currency swaps and foreign currency forwards to manage a portion of its fair value exposure to the DKK relative to the CAD for the Danish business classified as an investment in associate held for sale. Refer to Note 7.3 – Hedge of an investment in associate held for sale for more details. Cash flow hedges – The Company uses “fixed to fixed” interest rate swaps to hedge changes in the fair value of fixed income securities. The effective portion of changes in the fair value of the derivatives are recognized in OCI and the ineffective portion is recognized in Net gains (losses) in Net income.

Refer to Note 2.4 c) – Derivative financial instruments and hedging of the Company’s annual Consolidated financial

statements for the year ended December 31, 2020 for more details.

d) Restructuring provision A restructuring provision is recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation and the amount has been reliably estimated. A constructive obligation is when:

• there is a detailed formal plan that identifies the business or part of the business concerned, the location and number of employees affected, the detailed estimate of the associated costs, and the timeline; and

• the employees affected have been notified of the plan’s main features. The provision is measured at the present value of the expenditures expected to be required to settle the obligation. The restructuring provision primarily includes severances and provisions for onerous contracts. It can relate to the integration of a business acquired or to a restructuring to simplify the organization’s structure and drive efficiencies. The related expense is recognized in the line Acquisition, integration and restructuring costs.

e) Asset held for sale Assets are classified as held for sale when the carrying amount is to be recovered principally through a sale transaction rather than through continued use and such sale is considered highly probable. Assets held for sale are measured at the lower of their carrying amount or fair value less costs to sell.




Note 4 – Business combination

4.1 Business combination

The Company completed the following acquisition during the nine-month period ended September 30, 2021: RSA Insurance Group plc

On June 1, 2021, the Company, together with the Scandinavian P&C leader Tryg A/S (“Tryg”), completed the all-cash acquisition for

the entire issued share capital of RSA, a multinational insurance group with strong positions in the P&C insurance market in the UK,

Scandinavia and Canada along with supporting international business in Ireland, Continental Europe and the Middle East.

RSA shareholders received 685 pence per ordinary share from the Company which represented an aggregate cash consideration of

£7.2 billion ($12.3 billion). On the same day, the Company sold a portion of the Scandinavia operations to Tryg for £4.2 billion which

was used to partially fund the consideration paid to RSA’s shareholders. The total consideration paid to RSA shareholders consists

of:

• £3.0 billion ($5.1 billion) for the acquisition of RSA’s Canadian, UK and International operations and the 50% co-share of RSA’s Danish business; and

• £4.2 billion ($7.2 billion) for the acquisition of RSA’s Sweden and Norway businesses and the 50% co-share of RSA’s Danish business which was sold to Tryg on the same day. The disposed assets and associated liabilities are presented as held for sale in the fair value of assets acquired and liabilities assumed of Table 4.1 – Business combination.

Subsequently, on June 11, 2021, the Company announced that together with Tryg it had entered into a definitive agreement to sell RSA’s Danish business to Alm. Brand A/S Group (“Alm. Brand”) for a total cash consideration of approximately DKK12.6 billion ($2.6 billion) of which the Company will receive 50% of the proceeds of approximately DKK6.3 billion ($1.3 billion). Refer to Note 12 – Asset held for sale. In 2020, financing for the purchase price of $5.1 billion (£3.0 billion) for the Company’s retained portion, and related transaction fees of approximately $0.7 billion, was raised with $4.45 billion of private placement subscription receipts, a USD478 million ($577 million) bank term loan facility drawn on closing, $600 million of medium-term notes and the remaining balance was raised with $250 million of subordinated notes issued on March 31, 2021 (refer to Note 13 – Debt outstanding and Note 14 – Common shares and preferred shares). For more details, refer to Note 19 – Debt outstanding and Note 20 – Common shares and preferred shares of the Company’s annual Consolidated financial statements for the year ended December 31, 2020.

The Company hedged the purchase price and other items to foreign currency fluctuations. Refer to Note 7.2 – Currency hedging

in relation to the RSA acquisition.

As part of the acquisition, the Company assumed the full amount of RSA’s outstanding issued debt and other equity instruments which

totals £0.8 billion ($1.4 billion) and £0.4 billion ($0.7 billion), respectively as at June 1, 2021. Refer to Note 13 – Debt outstanding,

Note 15.2 – Tier 1 notes issued by RSA and Note 15.3 – Preferred shares issued by RSA.

The Company also retains and guarantees the obligations of the closed RSA UK pension schemes and has provided funding

commitments. Refer to Note 22.1 – Employee future benefits in relation to the RSA acquisition.

The acquisition expands the Company's leadership position in Canada, creates a leading specialty lines platform with international

expertise and provides an opportunity to enter the UK and Ireland markets at scale. The following table summarizes the consideration and the preliminary fair value of the assets acquired and liabilities assumed as at the acquisition date including the Scandinavian assets and liabilities held for sale. The provisional fair values have been reassessed since the second quarter of 2021 in light of additional information obtained during the measurement period following the acquisition. The adjustments were recorded prospectively since they were not significant. The final determination of the fair value will be completed within the prescribed period of one year following the acquisition.




Table 4.1 – Business combination

As at the acquisition date (June 1, 2021) GBP CAD

Purchase price

Cash consideration1 7,182 12,311 Purchase price hedge (Note 7.2) 28

Total purchase price 7,182 12,339

Fair value of the identifiable assets acquired and liabilities assumed

Assets

Investments2 8,331 14,283 Premiums receivable 2,305 3,952 Reinsurance assets 2,607 4,470 Deferred tax assets3 258 443 Deferred acquisition costs 538 921 Property and equipment 180 309 Intangible assets 1,223 2,096 Other 959 1,642 Assets held for sale4 8,982 15,399 Liabilities Claims liabilities (6,804) (11,664) Unearned premiums (3,105) (5,324) Deferred tax liabilities3 (256) (438) Debt outstanding5 (829) (1,421) Other (2,153) (3,691) Liabilities associated with assets held for sale4 (4,273) (7,326)

Total identifiable net assets acquired 7,963 13,651 Non-controlling interests (Note 15) (646) (1,108)

Gain on bargain purchase (135) (204)

Exchange rate (GBP/CAD) 1.71431

1 Includes proceeds from Tryg of $7.2 billion (£4.2 billion). 2 Includes cash and cash equivalents acquired of $1,263 million (£736 million). 3 Considers changes in the UK Corporate tax rate from 19% to 25% enacted in May 2021 and effective on April 1, 2023. 4 Represents RSA’s Sweden and Norway businesses and 50% of RSA’s Danish business sold to Tryg as well as the Company’s 50% interest in RSA’s

Danish business (Refer to Note 12 – Asset held for sale). 5 The Company repaid part of the debt assumed ahead of the maturity date (Refer to Note 13 – Debt outstanding).

The gain on bargain purchase of $204 million is non-taxable and represents the difference between the purchase price paid for RSA

and the fair value of the identifiable net assets acquired less the amount of non-controlling interests. The gain considers various items

including the difference between the valuation of the pension plan liability used to determine the transaction price and the recognition

and measurement principles defined by IAS 19 – Employee benefits. The fair value of the customer relationships, distribution networks, and trade names, included in intangible assets, is mainly based on a preliminary discounted cash flow analysis. The customer relationships, distribution networks and the trade names will be amortized over a three to seven year, six to twenty year and three to ten year period, respectively, and vary by country.

From June 1 to September 30, 2021, RSA’s contribution to NEP and Income before income taxes was $2,547 million and $139 million

respectively, using a GBP/CAD exchange rate of 1.72990. On a pro forma basis, for the nine-month period ended September 30,

2021, the NEP and Income before income taxes would have been $5,694 million and $204 million respectively if RSA was consolidated

from January 1, 2021. The pro forma basis was calculated using historical information without the Scandinavian operations, by

applying the Company’s accounting policies and assuming fair value adjustments that arose on acquisition would have been the same

if the acquisition occurred on January 1, 2021. The pro forma amounts exclude acquisition costs and benefits from integration

initiatives or synergies and are not necessarily indicative of the results that would have resulted if the acquisition occurred on January

1, 2021, or the results that may be obtained in the future.

For the three and nine-month periods ended September 30, 2021, the Company recorded acquisition costs of nil and $85 million respectively, mainly related to professional fees and stamp duties related to the closing of the acquisition. For the three and nine-month periods ended September 30, 2021, the Company also incurred integration costs of $93 million and $132 million respectively. These costs are reported in the line Acquisition, integration and restructuring.




Note 5 – Investments

5.1 Classification of investments

Table 5.1 – Classification of investments

Fair value Amortized cost

As at AFS Classified as FVTPL

Designated as FVTPL

Cash and cash equivalents, and

loans Total

carrying amount

September 30, 2021

Cash and cash equivalents - - - 3,014 3,014

Short-term notes 520 - - - 520 Fixed income Investment grade Government 5,250 - 3,647 - 8,897 Corporate 7,312 - 3,423 - 10,735 Asset-backed1 930 - 163 - 1,093 Mortgage-backed

Agency2 1,156 - 238 - 1,394 Non-agency 617 - 307 - 924

Below investment grade Corporate 53 - 9 - 62 Non-rated 1,331 - - - 1,331

Debt securities 17,169 - 7,787 - 24,956

Investment grade

Retractable 16 - - - 16 Fixed-rate perpetual 407 - - - 407 Other perpetual 1,500 - - - 1,500

Preferred shares 1,923 - - - 1,923

Common shares 3,426 14 1,754 - 5,194 Investment property - 552 - - 552 Loans - - - 986 986

22,518 566 9,541 4,000 36,625

December 31, 2020

Cash and cash equivalents - - - 917 917

Short-term notes3 684 - - - 684 Fixed income Investment grade Government 2,708 - 3,134 - 5,842 Corporate 2,270 - 2,968 - 5,238 Asset-backed1 366 - 76 - 442

Mortgage-backed Agency2 416 - 281 - 697 Non-agency 507 - 329 - 836

Below investment grade Corporate 20 - 4 - 24 Non-rated 335 - - - 335

Debt securities 7,306 - 6,792 - 14,098

Investment grade Retractable 21 - - - 21 Fixed-rate perpetual 303 - - - 303 Other perpetual 1,228 - - - 1,228

Preferred shares 1,552 - - - 1,552

Common shares 2,405 17 1,357 - 3,779 Loans - - - 284 284

11,263 17 8,149 1,201 20,630

1 Credit card receivables and auto loans. 2 Publicly traded MBS, which carry the full faith and credit guarantee of the US Government or are guaranteed by a government sponsored entity. 3 Includes the invested proceeds from the issuance of the $600 million from the Series 9 and 10 medium-term notes issued on December 16, 2020

(refer to Note 13 – Debt outstanding). These amounts were held in a segregated account with restricted use until the closing date of the RSA acquisition.




5.2 Carrying value of investments

Table 5.2 – Carrying value of investments

FVTPL

investments Other

investments Total

investments

As at Carrying

value Amortized

cost Unrealized

gains2 Unrealized

losses2 Carrying

value Carrying

value

September 30, 2021

Cash and cash equivalents - 3,014 - - 3,014 3,014 Debt securities 7,787 17,040 194 (65) 17,169 24,956 Preferred shares1 - 1,744 188 (9) 1,923 1,923 Common shares 1,768 3,031 453 (58) 3,426 5,194 Investment property 552 - - - - 552 Loans - 986 - - 986 986

10,107 25,815 835 (132) 26,518 36,625

December 31, 2020

Cash and cash equivalents - 917 - - 917 917 Debt securities 6,792 7,009 304 (7) 7,306 14,098 Preferred shares1 - 1,560 70 (78) 1,552 1,552 Common shares 1,374 2,181 292 (68) 2,405 3,779 Loans - 284 - - 284 284

8,166 11,951 666 (153) 12,464 20,630

1 Includes unrealized gains (losses) on embedded derivatives of $(61) million as at September 30, 2021 ($(12) million as at December 31, 2020). These derivatives were presented in Investments, with the related perpetual preferred shares, on the interim Consolidated balance sheets but their change in fair value was reported in Net gains (losses) in Net income.

2 Foreign amounts are translated using the period-end exchange rate.

The following tables present the credit quality of the Company’s debt securities and preferred shares.

Table 5.3 – Credit quality of debt securities

As at September 30,

2021 December 31,

2020

Debt securities AAA 27% 38% AA 31% 30% A 24% 21% BBB 12% 9% Not rated 6% 2%

100% 100%

Table 5.4 – Credit quality of preferred shares

As at September 30,

2021 December 31,

2020

Preferred shares

P1 2% - P2 77% 80% P3 21% 20%

100% 100%




5.3 Collateral and commitments in relation to the RSA acquisition

The following table summarizes the investment related collateral and commitments:

Table 5.5 – Collateral and commitments

As at September 30,

2021

Collateral: pledged for liabilities or contingent liabilities mainly consisting of debt and cash and cash equivalents 625 accepted mainly consisting of debt securities (the Company is permitted to sell or repledge in the event of

default by the owner)1 1,058

Commitments: investments in property funds and collateralized debt obligations 44 other classes of investments 787

1 The obligation to repay the cash is included in other liabilities and the corresponding receivable is recognized as an asset.

Note 6 – Financial liabilities related to investments

Table 6.1 – Financial liabilities related to investments

As at September 30,

2021 December 31,

2020

Accounts payable to investment brokers on unsettled trades 346 43 Derivative financial liabilities (Table 7.1) 176 38 Equities sold short positions 9 8

531 89




Note 7 – Derivative financial instruments

7.1 Fair value and notional amount of derivatives

The Company uses derivatives for economic hedging purposes and for the purpose of improving the risk profile of its investment

portfolio, as long as the resulting exposures remain within the guidelines of its investment policy. In certain circumstances, these

hedges also meet the requirements for hedge accounting. Risk management strategies eligible for hedge accounting have been

designated as net investment hedges in foreign operations, cash flow hedges and fair value hedges.

Table 7.1 – Fair value and notional amount of derivatives

September 30, 2021 December 31, 2020

Notional amount

Fair value Notional amount

Fair value

As at Asset Liability Asset Liability

Foreign currency contracts Forwards 5,616 18 45 10,328 154 23 Cross currency swaps 605 32 - 266 12 - Interest rate contracts Futures 918 - - 1,841 - - Swaps 93 - 11 - - - Foreign currency and interest rate contracts Cross currency interest rate swaps 186 3 19 - - - Equity contracts Swaps 1,739 29 40 1,348 - 15 Futures 400 - - 427 - - Inflation contracts Swaps 205 69 61 - - -

9,762 151 176 14,210 166 38

Held for risk management purposes Designated as net investment hedges 4,042 16 34 2,447 123 - Designated as cash flow hedges 411 3 17 - - - Designated as fair value hedges 1,019 33 13 - - - Not designated 4,121 99 112 11,628 43 38

9,593 151 176 14,075 166 38

Held for trading purposes 169 - - 135 - -

9,762 151 176 14,210 166 38

Term to maturity: less than one year 9,157 12,312 from one to five years 273 1,898 over five years 332 -

9,762 14,210




7.2 Currency hedging in relation to the RSA acquisition

Purchase price hedges

In November 2020, in connection with the RSA acquisition, the Company entered into foreign currency forward contracts in order to

hedge the £3.0 billion ($5.1 billion) purchase price to exposures from fluctuations in the CAD/GBP and EUR/GBP currency pairs.

These derivatives had a notional of £2.7 billion ($4.6 billion) GBP/CAD and £0.3 billion ($0.5 billion) GBP/EUR, of which £2.4 billion

($4.1 billion) were contingent on the closing of the acquisition.

On January 18, 2021 (RSA’s shareholder approval date), the RSA acquisition was considered highly probable and the purchase price

hedge was designated as a cash flow hedge. From this date, the effective portion of changes in the fair value of GBP/CAD derivatives

with a notional value of £2.1 billion ($3.6 billion) was recognized in OCI and the ineffective portion was recognized in Net gains (losses)

in Net income. On closing, losses of $32 million ($28 million net of tax) was recognized in AOCI and was reclassified as part of the

purchase price consideration for RSA. Before January 18, 2021, these derivatives did not qualify as cash flow hedges. As a result,

the changes in the fair value were recognized in Net gains (losses) in Net income. These contracts were settled upon closing of the

acquisition.

Refer to Note 4.1 – Business combination for more details.

Book value hedges

In November 2020, the Company also entered into foreign currency forward contracts for a notional of £700 million ($1.2 billion),

whereby it sells GBP for CAD, in order to reduce its book value exposure to the GBP. These derivatives represented economic hedges

and the changes in the fair value were recognized through Net income until closing of the transaction. At the time of closing, the

Company designated these forward contracts as a net investment hedge of its foreign operations in RSA. The effective portion of

changes in fair value was recognized in OCI and the ineffective portion was recognized in Net gains or losses in Net income.

The Company also entered into other foreign currency forward contracts for a net notional of £100 million ($171 million) CAD/GBP for

risk management purposes related to the RSA acquisition. These contracts were settled upon closing of the acquisition.

In September 2021, the Company hedged an additional £275 million ($469 million) using foreign currency forward contracts. The

Company also reduced its USD book value hedge by USD200 million.


7.3 Hedge of an investment in associate held for sale

The Company hedged its exposure to the DKK relative to the CAD for the Danish business classified as an investment in associate

held for sale. The Company uses a USD denominated bank term loan together with cross-currency swaps equivalent to DKK2.9 billion

($0.6 billion) (the “synthetic term loan”) and foreign currency forwards of DKK1.4 billion ($0.3 billion) to manage its fair value exposure.

The synthetic term loan and the forwards were designated as hedging instruments in a fair value hedge and as a result their gains or

losses are recorded in Net gains or losses in Net income together with foreign exchange translation gains or losses on the asset held

for sale. On July 1, 2021, the transaction was considered highly probable and foreign currency forwards used to hedge the remaining

exposure to the selling price were designated as a cash flow hedge. The effective portion of changes in the fair value of the hedging

instrument was recognized in OCI and the ineffective portion was recognized in Net gains or losses in Net income.

Refer to Note 12 – Asset held for sale for more details.




Note 8 – Fair value measurement

8.1 Categorization of fair values

Table 8.1 – Fair value hierarchy of financial assets and financial liabilities

Level 1 Level 2 Level 3 Total

As at

Valued using quoted

(unadjusted) market prices

Valued using models (with

observable inputs)

Valued using models (without

observable inputs)

September 30, 2021

Short-term notes 520 - - 520

Fixed income

Investment grade

Government 4,268 4,629 - 8,897

Corporate - 10,735 - 10,735

Asset-backed - 1,093 - 1,093

Mortgage-backed

Agency - 1,394 - 1,394

Non-agency - 920 4 924

Below investment grade Corporate - 62 - 62

Non-rated - 33 1,298 1,331

Debt securities 4,788 18,866 1,302 24,956

Preferred shares1 1,923 - - 1,923

Common shares 4,971 2 221 5,194

Investment property - - 552 552

Derivative financial assets (Table 7.1) - 151 2 153

Total financial assets measured at fair value 11,682 19,019 2,077 32,778

Total financial liabilities measured at fair value (Table 6.1) 9 176 - 185

December 31, 2020

Short-term notes 459 225 - 684

Fixed income

Investment grade

Government 2,541 3,301 - 5,842

Corporate - 5,238 - 5,238

Asset-backed - 442 - 442

Mortgage-backed

Agency - 697 - 697

Non-agency - 836 - 836

Below investment grade Corporate - 24 - 24

Non-rated - - 335 335

Debt securities 3,000 10,763 335 14,098

Preferred shares1 1,552 - - 1,552

Common shares 3,751 - 28 3,779

Derivative financial assets (Table 7.1) - 166 - 166

Total financial assets measured at fair value 8,303 10,929 363 19,595

Total financial liabilities measured at fair value (Table 6.1) 8 38 - 46

1 Includes perpetual preferred shares with call options amounting to $1,658 million as at September 30, 2021 ($1,373 million as at December 31, 2020). The fair value of the embedded derivatives component amounting to $131 million as at September 30, 2021 ($63 million as at December 31, 2020) was determined using a Level 3 methodology.

The fair value of loans was $989 million as at September 30, 2021 ($290 million as at December 31, 2020). The carrying value of

certain short-term financial instruments not measured at fair value is a reasonable approximation of their fair value.




Note 9 – Financial risk

9.1 Sensitivity analysis to market risk

Sensitivity analysis is a risk management technique to assist management in ensuring that risks assumed remain within the

Company’s risk tolerance level. Sensitivity analyses involve varying a single factor to assess the impact that this would have on the

Company’s results and financial condition excluding any management action. Actual results can differ materially from these estimates

for a variety of reasons and therefore, these sensitivities should be considered as directional estimates.

Table 9.1 – Sensitivity analysis (after tax)


For the periods ended Net income OCI Net income OCI

Equity price risk

Common share prices (10% decrease)1 24 (402) 11 (221)

Preferred share prices (5% decrease) 2 19 (91) 12 (68)

Property price risk (10% decrease)1 (45) (39) - -

Interest rate risk (100 basis point increase)

Debt securities3,4 (235) (451) (198) (197) Net claims liabilities 377 200 - Defined benefit pension plan obligation, net of related debt

securities - 20 - 130

Currency risk5

Strengthening of CAD by 10% vs all currencies

Net assets of foreign operations in:

USD 9 (300) 6 (196)

GBP 5 (336) - -

Currency derivatives related to the RSA acquisition - - - (283)

Strengthening of GBP by 10% vs EUR

Currency derivatives related to the RSA acquisition - - (52) -

1 Including the impact of common shares (net of any equity hedges, including the impact of any impairment) or investment property related to the defined benefit pension plan.

2 Including the impact on related embedded derivatives. 3 Excludes the impact of debt securities related to the defined benefit pension plan. 4 Interest rate sensitivity is based on the fixed-income portfolio, which comprises approximately 45% of both government-related and 55% of corporate-

related securities. 5 After giving effect to forward-exchange contracts.

The sensitivity analysis was prepared using the following assumptions:

• Shifts in the yield curve are parallel;

• Interest rates, equity prices, property prices and foreign currency move independently;

• Credit, liquidity, spread and basis risks have not been considered;

• Impact on the Company’s pension plans has been considered; and

• Risk reduction measures perform as expected, with no material basis risk and no counterparty defaults.

AFS debt or equity securities in an unrealized loss position, as reflected in AOCI, may be realized through sale in the future.




9.2 Exposure to currency risk

Table 9.2 – Net foreign currency and translation exposure

As at September 30,

2021 December 31,

2020

Exposure in CAD USD1 GBP DKK/EUR2 USD

Investments supporting the Company’s Canadian operations 2,312 - - 2,198 Less: foreign-currency derivatives, notional amount (2,312) - - (2,179)

- - - 19

Consolidated net assets of foreign operations 2,584 3,306 606 2,304 Less: foreign-currency derivatives, notional amount - (1,331) (593) (254)

2,584 1,975 13 2,050

Other net assets denominated in foreign currency 60 (36) (857) 48 Less: foreign-currency derivatives, notional amount 6 - 857 -

Total net currency exposure 2,650 1,939 13 2,117

1 Includes the Company’s operations in the US and Middle East. 2 The DKK and EUR exposures are aggregated as the DKK continues to be pegged closely to the EUR.

9.3 Concentration of credit risk

Concentration of credit risk exists where several borrowers or counterparties are engaged in similar activities, are in the same

geographic area or have comparable economic characteristics. Their ability to meet contractual obligations may be similarly affected

by changing economic, political or other conditions. The Company’s investments could be sensitive to changing conditions in specific

geographic regions or industries.

Investments

The Company has a significant concentration of its investments in the financial sector and in Canada. These risk concentrations are

closely monitored. To provide sector diversification, the Company holds investment-grade non-financial US corporate bonds. The

newly acquired RSA foreign investment portfolio as well as the existing US and international securities reduce the concentration risk

in Canada.

Table 9.3 – Investment breakdown by country of incorporation and by industry

As September 30,

2021 December 31,

2020

By country of incorporation Canada 54% 72% US 19% 27% UK 12% - Other (including Ireland) 15% 1%

100% 100%

By industry Government 26% 34% Financials 35% 27% ABS and MBS 10% 10% Energy 4% 5% Other 25% 24%

100% 100%

9.4 Exposure to credit risk related to RSA’s structured settlements

As at September 30, 2021, RSA’s fair value of off-balance sheet structured settlements was $374 million. The related credit risk is minimal since the Company deals with registered life insurers and is mitigated by an industry compensation scheme, if a life insurer defaults, it would assume a significant majority of the remaining outstanding obligations. As at December 31, 2020, the Company’s fair value of off-balance sheet structured settlements was $1,552 million. Refer to Note 10.4 – Credit risk of the Company’s annual Consolidated financial statements for the year ended December 31, 2020, for more details.




Note 10 – Claims liabilities and reinsurance

10.1 Claims liabilities

Claims liabilities are established to reflect the estimate of the full amount of all liabilities associated with the insurance contracts earned

at the balance sheet date, including IBNR, that have occurred on or before the balance sheet date. The ultimate amount of these

liabilities will vary from the best estimate made for a variety of reasons, including additional information with respect to the facts and

circumstances of the insurance claims incurred. To recognize the uncertainty in establishing this best estimate, to allow for possible

deterioration in experience and to provide greater comfort that the actuarial liabilities are sufficient to pay future benefi ts, actuaries

are required to include margins in some assumptions. Refer to Note 11 – Claims liabilities of the Company’s annual Consolidated

financial statements for the year ended December 31, 2020, for more details on the significant accounting judgements, estimates and

assumptions used in relation to the COVID-19. At closing of the RSA acquisition, the Company’s risk margin was reviewed to ensure

risk margin assumptions reflect the benefit of additional diversification of insurance risk across lines of business and geographic

region.

Table 10.1 – Movements in claims liabilities

For the three-month periods ended Direct Ceded Net

September 30, 2021

Balance, beginning of period 24,483 4,318 20,165 Current period claims 3,452 389 3,063 Unfavourable (favourable) prior-year claims development (259) (116) (143) Increase (decrease) due to changes in discount rate (43) (6) (37)

Total claims incurred 3,150 267 2,883 Claims paid (2,673) (275) (2,398) Business combination (Note 4) - - - Exchange rate differences 46 13 33

Balance, end of period 25,006 4,323 20,683

September 30, 2020

Balance, beginning of period 12,571 1,407 11,164 Current period claims 1,687 60 1,627 Unfavourable (favourable) prior-year claims development 13 19 (6) Increase (decrease) due to changes in discount rate 41 4 37

Total claims incurred 1,741 83 1,658 Claims paid (1,516) (112) (1,404) Exchange rate differences (46) (17) (29)


For the nine-month periods ended Direct Ceded Net

September 30, 2021

Balance, beginning of period 12,780 1,381 11,399 Current period claims 7,360 607 6,753 Unfavourable (favourable) prior year claims development (602) (174) (428) Increase (decrease) due to changes in discount rate (168) (14) (154)

Total claims incurred 6,590 419 6,171 Claims paid (6,018) (493) (5,525) Business combination (Note 4) 11,664 3,023 8,641 Exchange rate differences (10) (7) (3)


September 30, 2020

Balance, beginning of period 11,846 1,300 10,546 Current period claims 5,170 190 4,980 Unfavourable (favourable) prior year claims development 22 74 (52) Increase (decrease) due to changes in discount rate 330 38 292

Total claims incurred 5,522 302 5,220 Claims paid (4,675) (262) (4,413) Exchange rate differences 57 21 36





10.2 Reinsurance

In the ordinary course of business, the Company reinsures certain risks with reinsurers to limit its maximum loss in the event of

catastrophic events or other significant losses. The following table shows the Company’s reinsurance net retention and coverage

limits by nature of risk.

Table 10.2 – Company’s reinsurance net retention and coverage limits by nature of risk

As at September 30,

2021 December 31,

2020

Single risk events

Retentions in Canada: on property policies 7.5 7.5 on liability policies 5 - 10 5 - 10

Retentions in the US (in USD):

on property policies 4 3 on liability policies 3 3

Multi-risk events and catastrophes

Retention 150 100 Coverage limits 5,300 5,300

For certain special classes of business or types of risks, the retention for single risk events may be lower through specific treaties or the use of facultative reinsurance. Effective January 1, 2021, the Company maintained its coverage limits but increased the retention to $150 million for multi-risk events and catastrophes. As at September 30, 2021, the Company retains participations averaging 9.2% on reinsurance layers between the retention and coverage limit (10.2% as at December 31, 2020). The coverage limit prudently exceeds the Company's risk assessment of an earthquake in Western Canada at a 1-in-500-year return period.

Refer to Note 14 – Reinsurance of the Company’s annual Consolidated financial statements for the year ended December 31, 2020

for further details.

RSA

As at September 30, 2021, the newly acquired operations of the Company are covered by its own reinsurance program for single risk

events as well as multi-risk events and catastrophes. Under the property catastrophe reinsurance program, the retention and limit

vary based on the location of the loss occurrence. In addition, the Company also purchases dedicated reinsurance protection for

certain lines of business and territories. The following table shows the Company’s main reinsurance net retention and coverage limits

by nature of risk and region.

Table 10.3 – RSA’s reinsurance net retention and coverage limits by nature of risk and region

As at September 30, 2021 Canada

(CAD) UK

(GBP)

Single risk events

Property retention 17 17

Multi-risk events and catastrophes

Retention 75 75 Coverage limit 3,200 1,350

In 2021, large net retained property risk and catastrophe losses are subject to an annual aggregate treaty. Coverage under this treaty

is triggered once cumulative qualifying large and catastrophe losses exceed £160 million, subject to a limit of £125 million and

Company retained participation of 25%.

On July 27, 2021, the Company entered into a reinsurance contract pursuant to which a third-party reinsurer will assume 50% of negative reserve development in excess of an agreed retention with respect to certain of RSA's UK&I and other claims liabilit ies for accident years 2020 and prior. The maximum amount recoverable from the third-party reinsurer under the reinsurance contract is 50% of £400 million and is subject to certain exclusions and limitations including in relation to first party COVID-19 related claims. The transaction closed on October 6, 2021, following regulatory approval and satisfaction of various closing conditions. The purchase of this adverse development coverage will reduce the potential volatility in the Company's claims liabilities and result in a release of risk margin in the fourth quarter. The net impact of the adverse development coverage, amounting to $65 million will be reported in Acquisition, integration and restructuring costs in Net income.




Table 10.4 – Components of reinsurance assets

As at September 30,

2021 December 31,

2020

Reinsurers’ share of claims liabilities (Table 10.1) 4,323 1,381 Reinsurers’ share of unearned premiums 1,413 152

5,736 1,533

Note 11 – Other assets and other liabilities

11.1 Other assets

Table 11.1 – Components of other assets

As at September 30,

2021 December 31,

2020

Pension plan in a surplus position 967 - Financial assets related to investments 401 230 Reinsurance receivable 356 137 Other receivables and recoverables 306 165 Industry pools receivable 199 168 Accrued investment income 195 83 Prepaids 175 114 Investments, at cost 172 121 Restricted funds 73 86 Premium and sale taxes receivable 55 44 Contract assets1 26 16 Other 125 37

3,050 1,201

1 Unbilled revenue related to supply chain operations.

During the three and nine-month periods ended September 30, 2021, there were no events or changes in circumstances that indicated

that the carrying value of investments at cost may not be recoverable.

11.2 Other liabilities

Table 11.2 – Components of other liabilities

As at September 30,

2021 December 31,

2020

Reinsurance payable 1,330 53 Commissions payable 861 297 Lease liabilities 699 447 Account payables and accrued expenses 584 233 Deposits received in connection with insurance contracts1 581 475 Premium and sale taxes payable 384 263 Accrued salaries and related compensation 327 261 Pension plans in a deficit position and unfunded plans 218 260 Industry pools payable 197 151 Other post-employment benefits and other post-retirement benefits 141 55 Provisions2 139 8 Other payable to broker 112 107 Deposits received from reinsurers 31 26 Contingent considerations3 19 37 Other payables and other liabilities 607 269

6,230 2,942

1 Unrestricted collateral held by the Company primarily in relation with the surety business. 2 Provisions were mainly related to the RSA acquisition and include restructuring provisions of $34 million as well as other provisions such as litigations

and lease dilapidations and refurbishments. 3 Recorded at fair value based on future profitability metrics, discounted using information as of the measurement date and classified in Level 3 of the

fair value hierarchy.




Note 12 – Asset held for sale

On June 1, 2021, the Company acquired RSA and on the same day, the Company sold a portion of the Scandinavia operations to Tryg for £4.2 billion ($7.2 billion). On June 11, 2021, the Company announced that together with Tryg it had entered into a definitive agreement to sell the Danish business to Alm. Brand for a total cash consideration of approximately DKK12.6 billion ($2.6 billion). The Company will receive 50% of the proceeds which represents approximately DKK6.3 billion ($1.3 billion). The transaction is expected to close in the first half of 2022, subject to the receipt of the relevant approvals or clearances from regulatory and antitrust authorities, the completion of Alm. Brand’s financing and the satisfaction or waiver of certain other conditions. As a result, the Company included the Scandinavian assets and liabilities as held for sale in its preliminary fair value of the assets acquired and liabilities assumed as at the acquisition date. The portion sold to Tryg on the same day is no longer presented in the consolidated balance sheets as at September 30, 2021 and the Company’s retained interest in the Danish business was classified as an investment in associate held for sale. Refer to 4.1 – Business combination for more details. At initial recognition, the investment in associate held for sale was recorded at its fair value less cost to sell of DKK4.3 billion ($0.9 billion) which was determined by allocating the total purchase price of the RSA acquisition. The Company hedged its fair value exposure to foreign exchange risk and as a result gains and losses on foreign currency translation on the asset held for sale and the hedging instrument were recognized in Net gains or losses in Net income. On July 1, 2021, the transaction was considered highly probable and foreign currency forwards used to hedge the remaining exposure to the selling price were designated as a cash flow hedge. The effective portion of changes in the fair value of the hedging instrument was recognized in OCI and the ineffective portion was recognized in Net gains or losses in Net income. Refer to Note 7.3 – Hedge of an investment in associate held for sale for more details.




Note 13 – Debt outstanding

13.1 New financing

Series 1 Subordinated

Notes

• On March 31, 2021, the Company completed an offering of $250 million principal amount of fixed-to-fixed rate

subordinated notes Series 1 (the “hybrid notes”), due March 31, 2081 with the option for the issuer to redeem

the hybrid notes every five years.

• The hybrid notes bear interest at a fixed annual rate of 4.125% for the initial five years until March 31, 2026,

subsequently the interest rate will be reset on that date and on every fifth anniversary of such date until

maturity on March 26, 2081 at a fixed interest rate per annum equal to the Government of Canada Yield on

the business day prior to such interest date reset plus 3.196%. Interest is payable in semi-annual instalments

commencing on September 30, 2021.

• The hybrid notes will be converted automatically into Non-cumulative Class A Series 10 preferred shares of

the Company upon certain bankruptcy or insolvency related events. The hybrid notes are direct unsecured

obligations and are subordinated to all senior indebtedness of the Company.

• The net proceeds from this offering were used to partly finance the RSA acquisition.

Series 11, 12 & 13 Unsecured

Medium-Term Notes

• On May 18, 2021, the Company completed a three-tranche offering of:

o $375 million Series 11 unsecured medium-term notes, which bears interest at a fixed annual rate of

1.207% until maturity on May 21, 2024, payable in semi-annual instalments commencing on

November 21, 2021;



November 18, 2021;



November 20, 2021.

• The net proceeds from this offering were used to fund the early redemption of:

o RSA’s £350 million 2019 Senior notes on June 16, 2021;

o the Company’s $300 million Series 4 unsecured medium-term notes on June 17, 2021; and

o the early redemptions resulted in fees of $30 million, offset by the reversal of fair value adjustments

on acquisition of $27 million, which were reported in Finance costs.

Commercial paper

• On October 7, 2021, the Company launched a Canadian commercial paper program, whereby it may issue

short-term promissory notes (“commercial paper”) up to an aggregate principal amount of $500 million.

• The commercial paper will be issued with maturities of less than one year at varying interest or discount rates

depending on prevailing market rates.

• The net proceeds will be used to finance the Company’s short-term liquidity needs.

• In October 2021, the Company issued a total of $471 million in commercial paper at a weighted average rate

of 0.27%. The proceeds were used to repay the Company’s credit facility.




13.2 Other financing

Term Loan and Medium-term notes in relation with the RSA acquisition On November 18, 2020, the Company entered into a 24-month bank term loan facility agreement which was drawn upon closing of the RSA acquisition for USD478 million ($577 million) at a rate of Libor plus 80bps.

On December 16, 2020, the Company completed an offering of $600 million principal amount of Series 9 and 10 unsecured medium-

term notes. The proceeds of these medium-term notes were held in a segregated account with the Company’s custodian and became

available at closing of the RSA acquisition.

Bridge financing facility in relation with the RSA acquisition On November 18, 2020, the Company secured a bridge financing facility (“bridge facility”) to be used if alternative financing was not available by closing of the acquisition. As at December 31, 2020, the amounts available under the bridge facility included a £341 million ($593 million) non-revolving equity bridge and a £47 million ($82 million) non-revolving bond bridge. In March 2021, with the issuance of the subordinated notes as described above, the non-revolving bond bridge facility was cancelled, and the non-revolving equity bridge facility was reduced to approximately £246 million ($426 million). In May 2021, with the issuances of the Series 11, 12 and 13 Medium-Term notes, the non-revolving equity bridge was also cancelled. Refer to Note 4.1 – Business combination for more details.

Credit facility The Company has an unsecured revolving term credit facility. On June 1, 2021, the credit facility was increased from $750 million to $1.5 billion in order to provide incremental liquidity and the maturity was extended by 18 months, it now matures on May 20, 2026. As at September 30, 2021, there was $472 million drawn under the credit facility which was subsequently repaid in October 2021 using the proceeds from the commercial paper issuance. As at December 31, 2020, no balance was drawn under this credit facility.

13.3 Debt outstanding assumed from the RSA acquisition

2019 Senior notes – On June 17, 2021, the Company repaid £350 million principal amount of debt assumed ahead of the maturity date which had a fair value of £364 million. Refer to Note 13.1 – New financing for more details. Guaranteed subordinated notes - The £400 million principal amount of bonds were issued on October 10, 2014 at a fixed rate of 5.13% and have a redemption date of October 10, 2045. The Company has the right to repay the notes on specific dates from October 10, 2025. If the bonds are not repaid at that time, the applicable interest rate would be reset at a rate of 3.852% plus the appropriate benchmark gilt for a further five-year period. Upon closing of the acquisition, the bonds were remeasured at fair value of £455 million using a quoted market price. On September 30, 2021, the Company redeemed £240 million principal amount of the notes ahead of the maturity date using its credit facility. The redemption price was £275 million, and the notes had a carrying value of £271 million reflecting fair value adjustments on acquisition. The net cost of £4 million ($7 million) was reported in Acquisition, integration and restructuring costs.

Subordinated guaranteed US bonds – The USD9 million principal amount of bonds were issued in 1999 and have a redemption

date of October 15, 2029 and the rate of interest payable on the bonds is 8.95%. Upon closing of the acquisition, the bonds were

remeasured at fair value of USD13 million using a quoted market price.

The Guaranteed subordinated notes and Subordinated guaranteed US bonds are contractually subordinated to all other creditors

such that in the event of a winding up or of bankruptcy, they are able to be repaid only after the claims of all other creditors have been

met. The Company has the option to defer interest payment but has not exercised this right to date.




13.4 Summary of debt outstanding

Table 13.1 – Carrying value of debt outstanding

Maturity date

Initial term

(years) Fixed

rate

Coupon

(payment) Principal

amount

Carrying value (net of fees)

As at, September 30,

2021 December 31,

2020

Medium-term notes Series 2 Nov. 2039 30 6.40% May & Nov. 250 248 248 Series 3 July 2061 50 6.20% Jan. & July 100 99 99 Series 4 Aug. 2021 10 4.70% Feb. & Aug. 300 - 300 Series 5 June 2042 30 5.16% June & Dec. 250 249 249 Series 6 Mar. 2026 10 3.77% Mar. & Sept. 250 249 249 Series 7 June 2027 10 2.85% June & Dec. 425 423 423 Series 8 Mar. 2025 5 3.69% Mar. & Sept. 300 299 298 Series 9 Dec. 2030 10 1.93% June & Dec. 300 298 298 Series 10 Dec. 2050 30 2.95% June & Dec. 300 298 298 Series 11 May 2024 3 1.207% May & Nov. 375 373 - Series 12 May 2028 7 2.179% May & Nov. 375 373 - Series 13 May 2053 32 3.765% May & Nov. 250 248 -

2012 US senior notes Nov. 2022 10 4.60% May & Nov. USD275 353 358 Term loans

USD term loan Nov. 2022 1.5 USD130 165 210 USD term loan facility (Note 13.2)

Jun. 2023

2

USD478 601 -

Subordinated notes Guaranteed subordinated notes in GBP (Note 13.3)

Oct. 2045

31

5.13%

Oct. £160 308 -

Subordinated guaranteed US bonds (Note 13.3)

Oct. 2029

30

8.95%

Apr. & Oct. USD9 17 -

Credit facility 472 - Other Debt Oct. 2028 4 11

Total debt outstanding before hybrid subordinated notes 5,077 3,041

Hybrid subordinated notes Series 1 (Note 13.1) Mar. 2081 60 4.13% Mar. & Sept. 250 247 -

Total debt outstanding 5,324 3,041

The fair value of debt outstanding amounted to $5,623 million as at September 30, 2021 ($3,482 million as at December 31, 2020) and was established using valuation data from a benchmark firm.




Note 14 – Common shares and preferred shares

14.1 New financing

Issuance of common shares

pursuant to subscription

receipts

On June 1, 2021, concurrent to the closing of the RSA acquisition:

• 23.8 million private placement subscription receipts (“receipts”) were converted into 23.8 million common

shares. The Company had completed its offering of the receipts on November 25, 2020 with three Canadian

institutional investors at a price of $134.50 per receipt for gross proceeds of $3.2 billion. The related issuance

costs of $140 million ($104 million after tax) were accounted for as a reduction in common shares, resulting

in net proceeds of approximately $3.1 billion.

• 9,272,000 receipts were converted into 9,272,000 common shares. The Company had completed its offering

of the receipts on December 3, 2020 with a group of underwriters at a price of $134.50 per receipt for gross

proceeds of $1.25 billion. The related issuance costs of $47 million ($35 million after tax) were accounted for

as a reduction in common shares, resulting in net proceeds of approximately $1.2 billion.

• The receipt holders received a dividend equivalent payment of $55 million which is equal to any common

share dividends declared by the Company from the date of their issuance to the closing of the acquisition.


14.2 Other financing

On August 31, 2021, the Company announced that it did not intend to exercise its right to redeem the Company’s Non-cumulative Rate Reset Class A Series 3 Preferred Shares (the “Series 3 Preferred Shares”) or the Non-cumulative Floating Rate Class A Series 4 Preferred Shares (the "Series 4 Preferred Shares") on September 30, 2021. Holders of Series 3 and Series 4 Preferred shares could elect to convert their shares into Series 4 and Series 3 shares respectively. As a result of the conversion, less than 1,000,000 Series 4 Preferred Shares remained outstanding therefore, they were automatically converted into Series 3 Preferred Shares on a one-to-one basis, on September 30, 2021 and were subsequently delisted on the same day.

14.3 Issued and outstanding

Table 14.1 – Issued and outstanding shares


As at Number of

shares Amount Number of

shares Amount

Common shares

176,081,958 7,576 143,018,134 3,265

Preferred shares - Class A Shares

Series 1

10,000,000 244 10,000,000 244 Series 3

10,000,000 245 8,405,004 206 Series 4

- - 1,594,996 39 Series 5

6,000,000 147 6,000,000 147 Series 6

6,000,000 147 6,000,000 147 Series 7

10,000,000 245 10,000,000 245 Series 9

6,000,000 147 6,000,000 147

Total Class A 48,000,000 1,175 48,000,000 1,175

Issued and outstanding Class A shares rank in priority to common shares with regards to payment of dividends.

Table 14.2 – Reconciliation of number of shares outstanding

Common shares (In shares)

As at September 30,

2021 December 31,

2020

Balance, beginning of period 143,018,134 143,018,134 Issued 33,063,824 -

Balance, end of period 176,081,958 143,018,134




Note 15 – Non-controlling interests

15.1 Non-controlling interests

As a result of the RSA acquisition, the Company recognized NCI of $1,108 million in its Consolidated balance sheets on acquisition. Refer to Note 4.1 – Business combination for more details. The NCI of the Company includes the following:

Table 15.1 – Non-controlling interests recognized in the consolidated balance sheet

As at September 30, 2021

Principal place of

business NCI

shares % NCI in

subsidiaries Dividends

to NCI3

Ownership interest in a subsidiary

Royal & Sun Alliance Insurance (Middle East) BSC (c)1 Middle East 50 327 1

Equity instruments issued by a subsidiary RSA Insurance Group plc2 UK n/a

Tier 1 510 13 Preferred shares 285 -

1,122 14

1 This entity owns 50% of the ordinary share capital of Al Alamiya for Cooperative Insurance Company, a company operating in the Kingdom of Saudi Arabia and 52.5% of Al Ahlia Insurance Company SAOG, a company operating in the Sultanate of Oman.

2 Related to the Tier 1 notes and Preferred shares issued by a subsidiary of the Company, as a result presented as NCI in the consolidated balance sheet. Refer to Note 15.2 and 15.3 below for more details.

3 For the period from the RSA acquisition on June 1 to September 30, 2021.

Upon closing of the RSA acquisition, the Company elected to measure the NCI in Royal & Sun Alliance Insurance (Middle East) BSC

(c) using the proportionate share method, which corresponds to the proportionate share of the value of the net identifiable assets

acquired.

15.2 Tier 1 notes issued by RSA

On March 27, 2017, RSA issued two floating rate Restricted notes (the “notes”) totalling $509 million in aggregate size and with a

blended coupon of 4.7%:

• Swedish Krona, 2,500 million at 3-month Stibor +525bps (equivalent to 4.8% coupon on issue)

• Danish Krone 650 million at 3-month Cibor +485bps (equivalent to 4.6% coupon on issue)

Interest on the notes is due and payable only at the sole and absolute discretion of the Company, subject to certain additional

restrictions and is non-cumulative. The notes are redeemable at the option of the Company in whole on the fifth anniversary of the

issue date, or any interest payment date thereafter or in the event of certain changes in the tax, regulatory or ratings treatments of

the notes. Any redemption is subject to permission of the relevant regulator. The notes convert into common shares of the Company,

at a pre-determined price if certain solvency capital requirements are breached, or in the event of a winding up occurring earlier.

Upon closing of the RSA acquisition, the Tier 1 notes were remeasured at fair value of $510 million (£298 million) using average

quotes obtained from different sources.

15.3 Preferred shares issued by RSA

The Company assumed preferred shares issued by RSA which have a nominal value of £1 each and are not redeemable, they have

preferential rights over the holders of RSA’s ordinary shares in respect of dividends and are entitled to a cumulative preferential

dividend of 7.375% per annum in semi-annual installments subject to approval by the Board. As at September 30, 2021, shares issued

and fully paid to preferred shareholders were 125,000,000.

Upon closing of the RSA acquisition, preferred shares were remeasured at fair value of $285 million (£166 million) using a quoted

market price.




Note 16 – Capital management

16.1 Capital management objectives

Capital management is a vital part of the financial management of the Company and is aligned with its strategy and business plan.

Capital is managed on a group basis as well as individually for each operating subsidiary.

The Company’s objectives when managing capital consist of:

• maximizing long-term shareholder value by optimizing capital used to operate and grow the Company; and

• maintaining strong regulatory capital levels to ensure policyholders are well protected.

16.2 Group capital position

Capital management at a group level focuses on optimizing overall capital within the various subsidiaries and ensuring there are sufficient liquid resources to support regulatory capital requirements, debt obligations, the payment of shareholder dividends, acquisitions and other business purposes. The capital strength of the group is measured by the Total Capital Margin. Total Capital Margin includes capital in excess of the internal CALs for insurance entities in Canadian, US, UK and other internationally regulated jurisdictions and the funds held in non-regulated entities less any ancillary own funds committed by the Company. The liquidity of the group is augmented with a credit facility currently with $1,500 million of undrawn capacity. Deployment of capital is performed in alignment with the Company’s financial objectives and executed within the context of its capital management policies and only after careful consideration of the impact on the Company’s risk metrics. Following the RSA acquisition, the Company expects to be classified as an Internationally Active Insurance Group (“IAIG”) and will continue to document its practices, policies and procedures to align with core outcomes of the International Association of Insurance Supervisors Framework for the Supervision of the IAIGs.

Table 16.1 – Total capital margin

As at September 30,

2021 December 31,

2020

Total Capital Margin 2,693 2,729

16.3 Regulatory capital

Each regulated insurance jurisdiction has its own supervisory capital ratio that is used to evaluate the ability of insurance companies

to meet all policy holder liabilities. As at September 30, 2021 and December 31, 2020, all the Company’s regulated P&C insurance

subsidiaries were well capitalized on an individual basis with capital levels in excess of regulator supervisory minimum levels and the

internal CAL. CALs represent the thresholds below which regulator notification is required together with a company action plan to

restore capital levels. These thresholds are reviewed annually as part of risk management practices.

With the acquisition of RSA, the Company is subject to other international regulations as described below. For further details on the Company’s capital and how it is managed in Canada and the US, refer to Note 21 – Capital management of the Company’s annual Consolidated financial statements for the year ended December 31, 2020.

UK&I

• RSA’s UK&I operations are subject to regulation and supervision by the Prudential Regulation Authority

(PRA).

• UK&I operations use an internal model compliant with the Solvency II regime enacted in the UK and approved

by the PRA to calculate the Solvency Capital Requirement (SCR).

• The coverage ratio represents total Eligible Own Funds over the SCR as determined by the internal model.

Table 16.2 – Estimated regulatory capital ratios

As at Regulatory

capital ratios CAL September 30,

2021 December 31,

2020

Canadian regulated entities MCT 165% / 200%1 204% 224% US regulated entities RBC 200% 441% 469% UK & International regulated entities SCR 120%2

176% -

1 The CAL is 165% MCT for the Company’s existing subsidiaries and is 200% for most of the newly acquired RSA Canadian insurance subsidiaries. 2 Indicated CAL and coverage ratios are for Royal & Sun Alliance Insurance Limited which includes all UK & International insurance entities.




Note 17 – Net investment income

Table 17.1 – Net investment income

Three months Nine months

For the periods ended September 30, 2021 2020 2021 2020

Interest income from: debt securities designated or classified as FVTPL 45 45 133 133 classified as AFS 66 39 145 120 loans and cash and cash equivalents 12 3 22 17

Interest income 123 87 300 270

Dividend income (expense) from: common shares, net designated or classified as FVTPL 20 18 57 52 classified as AFS 30 23 78 72 preferred shares classified as AFS 23 19 65 56 equities sold short positions - - - (1) investments, at cost - 1 1 1

Dividend income 73 61 201 180

Investment property rental income 6 - 8 -

Total investment income 202 61 509 180

Expenses (11) (5) (23) (16)

191 143 486 434




Note 18 – Net gains (losses)

18.1 Net gains (losses)

Table 18.1 – Net gains (losses)

For the three-month periods ended Sept. 30, 2021 2020

Portfolios Fixed

income Equity and

property Total Fixed

income Equity Total

Net gains (losses) from: financial instruments:

designated as FVTPL (43) 13 (30) 15 29 44 classified as FVTPL - 1 1 - (1) (1) classified as AFS1 2 (39) (37) 5 27 32

(41) (25) (66) 20 55 75 derivatives2: swap agreements - (17) (17) - (41) (41) forwards and futures 2 (4) (2) (1) (17) (18)

2 (21) (19) (1) (58) (59)

Embedded derivatives1 - (22) (22) - (22) (22) Investment property - 34 34 - - - Net foreign currency gains (losses) 23 - 23 - - - Impairment losses from common shares1 - (79) (79) - (3) (3)

(16) (113) (129) 19 (28) (9)

Currency derivative hedges related to the RSA acquisition (see Note 7.2):

Purchase price3 - - Book value - - Gain related to an investment in associate - - Other gains (losses) 41 22

(88) 13




For the nine-month periods ended Sept. 30, 2021 2020

Portfolios Fixed

income Equity and

property Total Fixed

income Equity Total

Net gains (losses) from: financial instruments:

designated as FVTPL (199) 390 191 244 (323) (79) classified as FVTPL - 6 6 - (7) (7) classified as AFS1 (12) 185 173 34 1 35

(211) 581 370 278 (329) (51) derivatives2: swap agreements - (412) (412) - 280 280 forwards and futures - (92) (92) (1) (5) (6)

- (504) (504) (1) 275 274

Embedded derivatives1 - (90) (90) - (2) (2) Investment property - 38 38 - - - Net foreign currency gains (losses) 39 - 39 - 11 11 Impairment losses from common shares1 - (81) (81) - (99) (99)

(172) (56) (228) 277 (144) 133

Currency derivative hedges related to the RSA acquisition (see Note 7.2):

Purchase price3 (71) - Book value 36 - Gain related to an investment in associate4 273 - Other gains (losses) 45 3

55 136

1 Includes losses recorded in Q3-2021 related to an Intact venture investment (refer to footnote 4), of which $110 million realized losses was mainly due to the partial sale of shares and $73 million was due to impairment losses.

2 Excluding foreign currency contracts, which are reported in the line net foreign currency gains (losses). 3 Including the changes in fair value related to the ineffective portion of the hedge and hedging premium associated with deal contingent forwards. 4 Mainly related to the disposal of an investment in associate in exchange for its publicly issued common shares in Q1-2021. This Intact venture

investment was classified as AFS.

Refer to Note 23 – Net gains (losses) of the Company’s annual Consolidated financial statements for the year ended December 31,

2020 for more details on the significant accounting judgements, estimates and assumptions used.




Note 19 – Income taxes

19.1 Income tax expense recorded in net income

Table 19.1 – Components of income tax expense recorded in net income



Current income tax expense (benefit)1 108 113 336 204 Deferred income tax expense (benefit) (17) (21) (26) (19)

91 92 310 185

1 Includes a current tax expense of $9 million recorded in Q1-2020 related to US corporate tax changes which limit tax deductions for interest payable on certain debt in a US subsidiary. The rules are applicable retroactive to January 1, 2019.

19.2 Effective income tax rate

The effective income tax rates are different from the combined Canadian federal and provincial statutory income tax rates. The interim

Consolidated statements of income contain items that are non-taxable or non-deductible for income tax purposes, which cause the

income tax expense to differ from what it would have been if based on statutory tax rates.

The following table presents the reconciliation of the effective income tax rate to the income tax expense calculated at statutory rates.

Table 19.2 – Effective income tax rate reconciliation



Statutory tax rates 25.9% 26.4% 25.9% 26.4% Increase (decrease) in income tax rates resulting from: non-taxable gain on bargain purchase (0.3)% - (3.1)% - non-deductible losses (non-taxable gains) 3.3% (1.2)% (1.2)% (0.3)% non-taxable investment income (3.3)% (3.1)% (2.3)% (5.5)% non-deductible losses (non-taxable income) from subsidiaries (1.5)% (0.7)% (1.1)% (1.1)%

change in unrecognized deferred income taxes 1.2% - (0.4)% - tax rates of subsidiaries, foreign entities, and associates (3.1)% (0.7)% (0.9)% (1.0)% adjustments related to the US Corporate Tax reform1 - 0.1% - 1.6% non-deductible expenses (0.5)% 0.2% 0.9% 0.4% other 1.6% 0.6% 0.5% 0.3%

Effective income tax rate 23.3% 21.6% 18.3% 20.8%

1 See Note 19.1 above for more details.

19.3 Dividend received deduction

In August 2021, the Company was reassessed by the CRA for additional income tax and interest with respect to the 2014, 2015 and 2016 taxation years. Also, the Company expects to receive reassessments from the ATRA and RQ in respect to the 2014, 2015 and 2016 taxation years. The expected total amount of additional income taxes and interest owed (including estimated provincial tax and interest) is approximately $14 million for the 2014 taxation year, $14 million for the 2015 taxation year and $12 million for the 2016 taxation year. In 2020, the CRA and ATRA reassessed the Company for additional income tax and interest in respect of the 2013 taxation year. Throughout the months of April and May 2021, the RQ also reassessed the Company for the same issue in respect of the 2013 taxation year. The total amount of additional income taxes and interest owed for the 2013 taxation year is approximately $9 million. All reassessments received to date have been paid in full and accordingly, no additional interest should be owing in the event of an unfavourable outcome. These tax authorities are denying certain dividend deductions on the basis that they were part of a “dividend rental arrangement”. The Company is confident that its tax filing position was appropriate and intends to defend itself vigorously. As a result, no amounts have been accrued in the interim Consolidated financial statements.




19.4 Unused tax losses and credits

As a result of the RSA acquisition, the Company has recorded $443 million of deferred tax assets, which was included in the acquired net assets of RSA. Refer to Note 4.1 – Business combination for more details. The following table presents unrecognized deferred tax assets as at September 30, 2021, in relation to the RSA acquisition:

Table 19.3 – Unrecognized unused tax losses and deductible temporary differences

As at September 30, 2021 Gross amount Tax effect Expiry date

Unused net operating losses UK 2,910 698 No expiry date Ireland 473 59 No expiry date Other jurisdictions 110 28 No expiry date Deductible temporary differences 732 177 No expiry date Unused allowable capital losses UK 2,192 526 No expiry date

Note 20 – Earnings per share

EPS was calculated by dividing the Net income attributable to common shareholders of the Company by the weighted-average number

of common shares outstanding during the period. Dilution is not applicable and, therefore, diluted EPS is the same as basic EPS.

Table 20.1 – Earnings per share



Net income attributable to shareholders 295 334 1,375 704 Less: dividends declared on preferred shares, net of tax (14) (13) (40) (39)

Net income attributable to common shareholders 281 321 1,335 665

Weighted-average number of common shares outstanding (in millions) 176.1 143.0 157.8 143.0

EPS – basic and diluted (in dollars) 1.60 2.25 8.46 4.65




Note 21 – Share-based payments

21.1 Long-term incentive plan

Table 21.1 – Movements in LTIP share units


For the periods ended September 30,

2021 (In units)

2020 (In units)

2021 (In units)

2020 (In units)

Outstanding, beginning of period 1,319,322 1,372,735 1,420,075 1,357,796

Awarded (forfeited) 126,510 1,825 483,406 376,914 Net change in estimate of units outstanding 87,452 32,057 123,810 (45,411) Units settled - - (494,007) (282,682)

Outstanding, end of period 1,533,284 1,406,617 1,533,284 1,406,617

The LTIP expense was $25 million and $60 million for the three and nine-month periods ended September 30, 2021, respectively ($21 million and $39 million for the three and nine-month periods ended September 30, 2020, respectively).

21.2 Employee share purchase plan

Table 21.2 – Movements in restricted common shares


For the periods ended September 30,

2021 (In units)

2020 (In units)

2021 (In units)

2020 (In units)

Outstanding, beginning of period 121,641 120,115 123,114 116,036

Accrued 29,022 33,292 87,027 95,330

Awarded and vested (32,976) (29,568) (90,870) (86,441) Forfeited (776) (381) (2,360) (1,467)

Outstanding, end of period 116,911 123,458 116,911 123,458

The ESPP expense was $4 million and $13 million for the three and nine-month periods ended September 30, 2021, respectively ($4 million and $12 million for the three and nine-month periods ended September 30, 2020, respectively).

21.3 Deferred share unit

The DSU provision amounted to $19 million as at September 30, 2021 ($18 million as at December 31, 2020).

21.4 Executive stock option plan

In May 2021, the Company established an Executive Stock Option Plan (“ESOP”) for certain key executive employees of the Company. Under the ESOP, the Human Resources and Compensation Committee may, at its discretion, from time-to-time grant options and stock appreciation rights (“SARs”) and also determines the terms and conditions of grants.

The options entitle participants to purchase common shares of the Company at an exercise price that is normally equal to the volume weighted average trading price per common share on the TSX on the day preceding the grant date. The options granted generally vest over three to seven years upon achievement of performance objectives and are exercisable within a ten-year period, except in the event of termination of employment or death.

As at September 30, 2021, 1,430,181 common shares have been reserved for issuance under the ESOP. On June 1, 2021, the Company approved a grant of 830,166 stock options with a grant date fair value of $20.05 per option using the Black-Scholes option pricing model. No SARs were granted as at September 30, 2021.

The fair value of the options is established on the grant date using the Black-Scholes option pricing model. The variables in the model include but are not limited to: the expected stock price volatility over the term of the awards, the expected life of the options, the dividend yield and the risk-free interest rate. The number of options expected to vest are estimated on the grant date and will be subsequently revised on each reporting date.

The fair value of the options, adjusted for expectations related to performance conditions and forfeitures, is accounted for as an equity-settled plan and is recognized as an expense over the vesting period with a corresponding credit to Contributed surplus. When the options are exercised, any consideration paid is credited to Common shares and the recorded fair value of the options is removed from Contributed surplus and credited to Common shares.

The ESOP expense was $1 million for the three and nine-month periods ended September 30, 2021, respectively.




21.5 Common shares repurchased for share-based payments

The settlement in shares with regards to the Company’s LTIP and ESPP plans is presented below.

Table 21.3 – Settlement in shares (LTIP and ESPP plans)



Value of common shares repurchased for share-based payments 6 4 59 45 Cumulative cost of the units for the Company 3 4 37 34

Excess of market price over the cumulative cost for the Company 3 - 22 11 Amount recognized in Retained earnings, net of taxes 2 - 16 9

The cumulative cost of the units that vested during the period through the plan administrator purchasing common shares on the market and remitting them to the participants was removed from Contributed surplus. The difference between the market price of the shares and the cumulative cost for the Company of these vested units, net of income taxes, was recorded in Retained earnings in the interim Consolidated financial statements.

Note 22 – Employee future benefits

22.1 Employee future benefits in relation to the RSA acquisition

RSA has DB pension plans in the UK, Canada, Ireland and other countries, with the most significant plans in the UK. RSA also provides post-employment healthcare benefits to certain current and retired Canadian employees and end-of-service indemnities to certain employees in the Middle East, in addition to defined contribution pension plans.

UK DB pension plans The plans were effectively closed to new entrants in 2002 and subsequently closed to future accruals with effect from March 31, 2017. The plan assets are mainly held in separate trustee administered funds. The plans in surplus are net a 35% tax expense of an authorized return of surplus; the Company does not believe the tax to be an income tax expense within the meaning of IAS 12 – Income taxes, but rather classifies it with “other net surplus remeasurements”.

Accrued benefits are revalued up to retirement in accordance with government indices for inflation. After retirement, pensions in payment are increased each year based on the increases in the government indices for inflation. The plans are managed through trusts with independent trustees responsible for safeguarding the interests of all members. The trustees meet regularly with RSA management to discuss the funding position and any proposed changes to the plans. The plans are regulated by The Pensions Regulator.

Each plan is subject to triennial valuations, which are used to determine the future funding. The effective date of the most recent valuations of the main UK funds was March 31, 2018.

At the most recent funding valuation, the main UK funds had an aggregate funding deficit of £468 million ($799 million), equivalent to

a funding level of 95%. On November 18, 2020, an agreement was reached with the pension trustees and the Company requiring the

following funding commitments:

• An additional contribution of approximately £75 million ($129 million) at closing;

• Continuation of current funding arrangements of approximately £75 million ($130 million) per year plus expenses and

regulatory levies until the schemes are fully funded on a previously agreed longer term funding basis; and

• The Company provides parental guarantees of the obligations.

The next funding valuation was due as at March 31, 2021 and will be completed before June 30, 2022.

Refer to Note 22.6 – Additional information on UK pension plans for more details.

Canada DB pension plans The net DB pension asset reported for certain plans has been limited further to the application of the accounting rules as clarified by IFRIC 14, as presented in line Other net surplus remeasurement of Table 22.1 – DB pension plan asset (liability) by country. For the affected plans, it was estimated that the fair value of plan assets, including expected future contributions, exceeds the amount needed to fulfil the plan’s obligations. The excess assets are not recognized on the Consolidated balance sheet. In determining a plan’s obligations for this purpose, future administration expenses expected to be charged to the pension fund were considered.




22.2 Funded status

The DB obligation, net of the fair value of plan assets, is recognized on the Consolidated balance sheets as an asset, when the plan is in a surplus position, or as a liability, when the plan is in a deficit position. This classification is determined on a plan-by-plan basis.

Table 22.1 – DB pension plan asset (liability) by country


As at UK1 Canada Other Total Canada

DB obligation (14,294) (3,465) (163) (17,922) (3,151) Fair value of plan assets 15,333 3,542 189 19,064 2,891 Other net surplus remeasurement (367) (26) - (393) -

Net DB asset (liability) 672 51 26 749 (260)

Reported in: other assets – plans in a surplus position

(Table 11.1) 682 257 28 967 - other liabilities – plans in a deficit position

and unfunded plans (Table 11.2) (10) (206)

(2) (218) (260)

672 51 26 749 (260) Funded status – funded plans 107% 109% 118% 108% 97%

1 The weighted average duration of the DB obligation of the two main UK schemes as at September 30, 2021 was 17 years.

In September 2021, as part of its de-risking strategy, the Company purchased qualifying annuity buy-in insurance contracts in the amount of $206 million on behalf of certain Canadian DB pension plans. The resulting actuarial loss was recognized in OCI. The fair value of annuity buy-in insurance contracts fluctuates based on changes in the associated DB obligation. In October 2021, the Company purchased additional qualifying annuity buy-in insurance contracts in the amount of $602 million on behalf of certain Canadian DB pension plans; the resulting actuarial loss will be recognized in OCI in the fourth quarter.

22.3 Employee future benefit expense recognized in net income

Table 22.2 – Employee future benefit expense recognized in net income

Pension plans



Current service cost 24 18 67 54 Net interest expense Interest expense on defined benefit obligation 98 21 153 63 Interest income on plan assets (102) (18) (154) (55) Other 4 1 9 3

24 22 75 65

22.4 Net actuarial gains (losses) recognized in OCI

Table 22.3 – Net actuarial gains (losses) recognized in OCI

Pension plans



Re-measurements related to: change in discount rate used to determine the benefit obligation 465 (48) 591 (172) actual return on plan assets 4 60 66 215 plan experience and change in other financial assumptions1 (443) (44) (315) 4 other (1) - (5) -

25 (32) 337 47

1 Changes in other financial assumptions are mainly related to inflation rate.




22.5 Assumptions used

The following table presents changes of certain key assumptions as disclosed in Note 27.6 – Significant accounting judgments,

estimates and assumptions of the Company’s annual Consolidated financial statements for the year ended December 31, 2020.

Table 22.4 – Key weighted-average assumptions used in measuring the Company’s pension plans

Pension Plans

2021 2020

As at September 30, UK Canada Other Canada

To determine the defined benefit obligation:

Discount rate 1.99% 3.51% 1.60% 2.83% Rate of increase in future compensation beyond 3 years n/a 2.73% n/a 2.29% Rate of inflation (CPI) 2.89% 1.98% 1.95% 1.54% Rate of inflation (RPI) 3.46% n/a 2.90% n/a Rate of increase in pensions1 3.16% n/a 1.95% n/a

1 For the UK the annual rate of increase in pensions shown is the rate that applies to pensions that increase at RPI subject to a cap of 5%. For other schemes the weighted average assumption is shown.

Pension Plans

2021 2020

For the three and nine-month periods ended September 30, UK Canada1 Other Canada

Discount rate to determine the benefit expense: current service cost n/a 2.86% n/a 3.18% interest expense on the DB obligation 1.94% 2.31% 1.40% 2.97%

1 For the nine-month period ended September 30, 2021, the discount rates used to determine the current service cost and the interest expense on the DB obligation were respectively 2.84% and 2.28%.

22.6 Additional information on UK pension plans

Table 22.5 – UK pension plan assets by quoted and unquoted

September 30, 2021

As at Total

quoted Total

unquoted

Total

Cash and cash equivalents (30) - (30) Government debt securities 10,764 - 10,764 Non-government debt securities 4,213 1,929 6,142 Common shares 890 39 929 Derivative financial instruments1 - 1,510 1,510 Property 1 1,110 1,111 Other - 590 590

Total investments 15,838 5,178 21,016 Value of asset and longevity swaps (see below) - (5,683) (5,683)

Total assets 15,838 (505) 15,333

1 The Company manages market, inflation and longevity risk using interest rate, inflation rate and longevity swaps. The Company will continue to work closely with RSA’s Pension Trustees to assess opportunities for further de-risking of the plans, including in respect of longevity risk.

In 2009, RSA entered into an arrangement that provides coverage against longevity risk for 55% of the retirement obligations relating to pensions in payment of the two largest UK plans at that time. The arrangement provides for reimbursement of the covered pension obligations in return for the contractual return receivable on a portfolio made up of quoted government debt of £4,851 million which was offset by swaps held by the pension funds of £3,329 million as at September 30, 2021. The swaps are accounted for as longevity swaps and are measured at fair value by discounting all expected future cash flows using a discounted rate which reflects the economic matching nature of the arrangement with a range of acceptable values obtained from external sources. As at September 30, 2021, the total value of the arrangement, including government debt measured at prices quoted in an active market was £1,522 million.




The following table presents the sensitivity analysis of the UK’s main DB pension obligation to key assumptions.

Table 22.6 – Sensitivity of the UK DB pension obligation to key assumptions

As at Change September 30, 2021

increase decrease

Discount rates 1% (2,077) 2,684 Rate of inflation 1% 1,370 (1,321) Life expectancy 1 year 614 (616)

The effect on the DB pension obligation at the end of the reporting period has been calculated by changing one assumption for the

sensitivity but without changing any other assumptions.

Note 23 – Segment information

23.1 Reportable segments

In connection with the RSA acquisition, the Company changed the composition of its reportable segments in the third quarter of 2021

to align with how senior management assesses its operating performance. The Company now has three reportable segments, in line

with its management structure and internal financial reporting which is based on country and the nature of its activities as described

below.

Canada

• Underwriting of automobile, home and business insurance contracts to individuals and businesses in Canada distributed through

a wide network of brokers and directly to consumers, including the results of RSA’s Canadian operations since July 1, 2021.

• Distribution and other include the results from the Company’s wholly owned subsidiaries (Brokerlink Inc. and Intact Public Entities

Inc. (formerly Frank Cowan Company Limited)) and broker affiliates including the results of RSA’s Canadian operations since July

1, 2021, as well as supply chain operations from On Side Developments Ltd.

US

• Underwriting of specialty contracts mainly to small and midsize businesses in the United States. The Company distributes insurance

through independent agencies, brokers, wholesalers and managing general agencies.

UK & International

• Underwriting of automobile, home, pet and business insurance contracts to individuals and businesses in the UK, Europe, Ireland

and Middle East as well as internationally through the Company’s global network since July 1, 2021. The Company distributes

insurance through a wide network of affinity partners and brokers or directly to consumers.

Corporate and Other (“Corporate”) consists of investment management, treasury and capital management activities, as well as other

corporate activities, including certain internal and external reinsurance agreements. The results of RSA’s Canadian and UK&I

operations for June 2021 were included in Corporate and Other as it was not significant.

23.2 Segment operating performance

All segment operating revenues presented in Table 23.1 – Segment operating performance are generated from external customers. Management measures the profitability of the Company’s segments based on PTOI which excludes elements that are not representative of the Company’s operating performance because they relate to special items, bear significant volatility from one period to another, or because they are not part of the Company’s normal activities. In addition, the Company presents:

• Other underwriting revenues against Net claims incurred (before MYA) and Underwriting expenses, which as a result, are not included in segment operating revenues;

• Share of profit from investments in associates & JV before interest and taxes from affiliated brokers (“broker associates”);

• Finance costs including finance costs from broker associates. The reconciliation of the segment information to the amounts reported in the interim Consolidated statements of income is presented in Table 23.2 – Reconciliation of segment information to amounts reported in the interim Consolidated statements of income.




Table 23.1 – Segment operating performance1

2021 2020

For the three-month periods ended Sept. 30, Canada UK&I US Corp. Total Canada US Corp. Total

Operating income NEP 3,280 1,174 415 2 4,871 2,479 383 1 2,863 Investment income - - - 202 202 - - 148 148 Other 110 - - 6 116 78 - 3 81

Segment operating revenues 3,390 1,174 415 210 5,189 2,557 383 152 3,092

Net claims incurred (before MYA) (1,875) (699) (228) (31) (2,833) (1,393) (212) - (1,605) Underwriting expenses (1,049) (403) (157) (3) (1,612) (739) (150) - (889) Investment expenses - - - (11) (11) - - (5) (5) Share of profit from invest. in associates & JV 36 - - - 36 32 - - 32 Finance costs (2) - - (45) (47) (2) - (29) (31) Other (41) - - (17) (58) (29) - (19) (48)

PTOI 459 72 30 103 664 426 21 99 546 Operating income taxes (140) (135) NCI (5) - Preferred share dividends (14) (13)

NOI attributable to common shareholders 505 398

PTOI is comprised of: underwriting income 356 72 30 (32) 426 347 21 1 369 net investment income - - - 191 191 - - 143 143 distribution EBITA 105 - - - 105 81 - - 81 finance costs (2) - - (45) (47) (2) - (29) (31) other income (expense) - - - (11) (11) - - (16) (16)

2021 2020

For the nine-month periods ended Sept. 30, Canada UK&I US Corp. Total Canada US Corp. Total

Operating income NEP 8,154 1,174 1,167 617 11,112 7,187 1,150 4 8,341 Investment income - - - 509 509 - - 450 450 Other 291 - - 22 313 227 - 9 236

Segment operating revenues 8,445 1,174 1,167 1,148 11,934 7,414 1,150 463 9,027

Net claims incurred (before MYA) (4,485) (699) (625) (391) (6,200) (4,239) (653) - (4,892) Underwriting expenses (2,657) (403) (461) (204) (3,725) (2,186) (451) - (2,637) Investment expenses - - - (23) (23) - - (16) (16) Share of profit from invest. in associates & JV 119 - - - 119 89 - - 89 Finance costs (8) - - (111) (119) (8) - (86) (94) Other (125) - - (51) (176) (113) - (48) (161)

PTOI 1,289 72 81 368 1,810 957 46 313 1,316 Operating income taxes (407) (312) NCI (12) - Preferred share dividends (40) (39)

NOI attributable to common shareholders 1,351 965

PTOI is comprised of: underwriting income 1,012 72 81 22 1,187 762 46 4 812 net investment income - - - 486 486 - - 434 434 distribution EBITA 285 - - - 285 203 - - 203 finance costs (8) - - (111) (119) (8) - (86) (94) other income (expense) - - - (29) (29) - - (39) (39)

1 See Section 23 – Non IFRS financial measures of the Company’s interim MD&A for the definition and reconciliation of related operating measures.




Table 23.2 – Reconciliation of segment information to amounts reported in the interim Consolidated statements of income



Segment operating revenues (Table 23.1) 5,189 3,092 11,934 9,027 Add: other underwriting revenues 77 34 157 99 Add: NEP from exited lines 79 1 123 1

Revenues, as reported in the interim Consolidated statements of income 5,345 3,127 12,214 9,127

Segment PTOI (Table 23.1) 664 546 1,810 1,316 Non-operating items1:

net gains (losses) (88) 13 55 136 gain on bargain purchase 4 - 204 - positive (negative) impact of MYA on underwriting 37 (37) 154 (292) amortization of intangible assets recognized in business

combinations (66) (38) (136) (114) acquisition, integration and restructuring costs (115) (25) (296) (62) non-operating pension expense (16) (13) (48) (40) underwriting results from exited lines (21) (12) (18) (23) other non-operating costs - (2) (2) (15)

Pre-tax income, as reported in the interim MD&A 399 432 1,723 906

Less: income taxes from broker associates (8) (6) (26) (17)

Pre-tax income, as reported in the interim Consolidated statements of income 391 426 1,697 889

1 See Section 22 – Non-operating results of the Company’s interim MD&A for the definition of related non-operating measures.

23.3 Selected segment assets and liabilities

Table 23.3 – Selected segment assets and liabilities


As at Canada UK&I US Corp. Total Canada US Corp. Total

Investments - - - 36,625 36,625 - - 20,630 20,630 Net claims liabilities (Table 10.1) 13,622 5,339 1,588 134 20,683 9,869 1,530 - 11,399

23.4 Significant operating subsidiaries by geographic areas

The Company’s significant operating subsidiaries by geographic areas of operations are presented below.

Table 23.4 – Significant operating subsidiaries by geographic areas

Operations Legal entities

Canada • Belair Insurance Company Inc.

• Brokerlink Inc.

• Canadian Northern Shield Insurance Company

• Equisure Financial Network Inc.

• Intact Insurance Company

• Intact Public Entities Inc.

• IB Reinsurance Inc.

• Jevco Insurance Company

• Novex Insurance Company

• On Side Developments Ltd.

• Quebec Assurance Company

• Royal & Sun Alliance Insurance Company of Canada

• The Johnson Corporation

• The Nordic Insurance Company of Canada

• Trafalgar Insurance Company of Canada

• Unifund Assurance Company

• Western Assurance Company

US • Atlantic Specialty Insurance Company

• Intact Insurance Group USA Holdings Inc.

• Intact U.S. Financial Services Inc.

• Split Rock Insurance, Ltd.

• The Guarantee Company of North America USA

UK&I • Al Alamiya for Cooperative Insurance Company

• Al Ahlia Insurance Company SAOG

• Royal & Sun Alliance Insurance Limited

• Royal & Sun Alliance Insurance (Middle East) BSC (c)

• RSA Luxembourg S.A.

• RSA Insurance Ireland DAC




Note 24 – Additional information on the interim Consolidated statements of cash flows

24.1 Adjustments for non-cash items

Table 24.1 – Adjustments for non-cash items



Depreciation of property and equipment1 39 32 105 85 Amortization of intangible assets 101 48 216 144 Net premiums on debt securities classified as AFS 46 9 81 22 DB pension expense 24 22 75 65 Share-based payments expense 30 25 74 51 Share of profit from investments in associates and joint ventures (22) (16) (71) (35) Other 7 1 (22) (2)

225 121 458 330

1 Includes depreciation of right-of-use assets of leases.

24.2 Changes in other operating assets and liabilities

Table 24.2 – Changes in other operating assets and liabilities



Unearned premiums, net 330 279 610 470 Premium’s receivable, net (140) (148) (145) (244) Deferred acquisition costs 2 (24) (49) (70) Other operating assets 57 (85) 168 (113) Other operating liabilities 37 116 (126) 61 Dividends received from investments in associates and joint ventures 7 7 21 18

293 145 479 122

Note 25 – Standards issued but not yet effective

There have been no significant updates to Note 33 – Standards issued but not yet effective of the Company’s annual Consolidated

financial statements for the year ended December 31, 2020, except as described below:

25.1 Insurance contracts

The Company is currently assessing the impact of the RSA acquisition on the IFRS 17- Insurance contracts and IFRS 9 programs.

25.2 Deferred tax related to assets and liabilities arising from a single transaction

In May 2021, the IASB issued narrow scope amendments to IAS 12 – Income taxes, to clarify how companies should account for deferred tax on certain transactions and events that lead to the initial recognition of both an asset and a liability. The amendments narrow the scope of the initial recognition exemption so that it does not apply to transactions that give rise to equal and offsetting temporary differences, such as leases and decommissioning obligations. The amendments apply prospectively to annual periods beginning on or after January 1, 2023, with earlier application permitted. The Company is currently assessing the impact of these amendments but does not expect any significant impact from their adoption.

Documents

Third Quarter 3